Not all medications are involved and only specific national drug numbers and blister pack lots distributed by Sandoz and Novartis in the US are affected.
Patients should continue taking the medicine as directed by their physician, secure the affected blister packs so that they are out of the sight and reach of children, and contact Novartis at 1-888-NOW NOVA or 1-888-669-6682 for full information on the list of affected products and instructions. Products in bottles are NOT impacted by this recall.
Sandoz focuses on generic pharmaceuticals and biosimilars. A division of the Novartis Group, its purpose is to discover new ways to improve and extend people's lives and to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. The company's portfolio of approximately 1000 molecules, covering all major therapeutic areas, accounted for 2016 sales of 10.1 bn. In 2016, its products reached well over 500 million patients.
Novartis Pharmaceuticals is an affiliate of Novartis which provides innovative healthcare solutions that address the evolving needs of patients and societies.
Par Pharmaceutical starts shipping colchicine 0.6mg capsules
Padagis launces Brinzolamide Ophthalmic Suspension with CGT exclusivity
Novartis completes Sandoz Spin-off
Novartis completes Sandoz spin-off, focusing on innovative medicines
Hikma marks KLOXXADO two-year anniversary by surpassing 375,000 doses donated in the US
STADA seeks full approval for Kinpeygo in IgA nephropathy from UK MHRA
Azurity Pharmaceuticals completes Slayback Pharma acquisition
Sandoz secures European approval for Tyruko biosimilar in MS treatment
Senores Pharmaceuticals introduces Nicardipine Hydrochloride Capsules USP, 20mg and 30mg in US
Lupin collaborates with Mark Cuban Cost Plus Drug Company and COPD foundation
Certara Simcyp receives FDA grants for advanced pharmacokinetic modelling
Sandoz's Tyruko (natalizumab-sztn) gains FDA approval as first biosimilar for relapsing MS
Nephron Pharmaceutical names new chief procurement officer
Lupin Pharmaceuticals launches Tiotropium Bromide Inhalation Powder, 18mcg/capsule in US